S109 Contribution of aberrant monocyte-natural killer T (NKT) cell axis to immune-pathology in sarcoidosis

INTRODUCTION: Sarcoidosis is a multisystem disorder characterisedby an overactive CD4 (T-helper 1) cell response to an undefined antigen, macrophage activation and granuloma formation. It has also been shown that monocytes (precursors to macrophages) are increased in sarcoidosis. We have shown that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2011-12, Vol.66 (Suppl 4), p.A50-A51
Hauptverfasser: Crawshaw, A. P., Kok, W. L., Denney, L., Ho, L.-P.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:INTRODUCTION: Sarcoidosis is a multisystem disorder characterisedby an overactive CD4 (T-helper 1) cell response to an undefined antigen, macrophage activation and granuloma formation. It has also been shown that monocytes (precursors to macrophages) are increased in sarcoidosis. We have shown that NKT cells, a specialised subset of immuneregulatory T cells, are deficient in sarcoidosis, and that in NKT knock-out mice, monocytes accumulate at sites of inflammation in both models of influenza A infection and multiple sclerosis. Here, we hypothesise that NKT cells control monocyte function and that NKT cell deficiency in sarcoidosis results in abnormal monocyte activity. METHODS: Twenty-five steroid-naieve non-smoking patients with histological confirmation of sarcoidosis were recruited from the Sarcoidosis-ILD service. Circulating monocyte numbers and phenotype were first characterised using multi-colour flow cytometry. We then isolated monocytes from blood using magnetic microbeads, examined cytokine production after LPS stimulation with intracellular cytokine FACS staining and ELISA; and using monocyte-NKT cell co-culture assays, questioned whether NKT cells affected these monocytic functions. RESULTS: We found an increase in circulating CD14CD16 inflammatory monocytes in patients with sarcoidosis, and identified a population of interleukin 10 producing monocytes in patients and controls after LPS stimulation. Monocytes from sarcoidosis patients have reduced capacity to produce IL-10 after LPS stimulation compared to control (6.37% vs 11.71% of total monocytes, p
ISSN:0040-6376
DOI:10.1136/thoraxjnl-2011-201054b.109